FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

404856006: Emtricitabine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2148686015 Emtricitabine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2156735019 Emtricitabine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Emtricitabine (substance) Is a Reverse transcriptase inhibitor true Inferred relationship Some
Emtricitabine (substance) Has disposition (attribute) Reverse transcriptase inhibitor (disposition) true Inferred relationship Some
Emtricitabine (substance) Is a Chemical categorized functionally false Inferred relationship Some
Emtricitabine (substance) Is a Pyrimidine true Inferred relationship Some
Emtricitabine (substance) Is a Transferase inhibitor false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing emtricitabine (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Emtricitabine (substance) Inferred relationship Some
Product containing emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has active ingredient False Emtricitabine (substance) Inferred relationship Some
Emtricitabine 10mg/mL s/f oral solution Has active ingredient False Emtricitabine (substance) Inferred relationship Some
Product containing efavirenz and emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has active ingredient False Emtricitabine (substance) Inferred relationship Some
Product containing emtricitabine and rilpivirine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Product containing emtricitabine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine-containing product in oral dose form Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has active ingredient False Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Emtricitabine (substance) Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has active ingredient False Emtricitabine (substance) Inferred relationship Some 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 3
Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Emtricitabine (substance) Inferred relationship Some 7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Emtricitabine (substance) Inferred relationship Some 7
Emtricitabine 10 mg/mL oral solution Has active ingredient False Emtricitabine (substance) Inferred relationship Some
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 3
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has precise active ingredient False Emtricitabine (substance) Inferred relationship Some 2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Emtricitabine (substance) Inferred relationship Some 3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Emtricitabine (substance) Inferred relationship Some 3
Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing bictegravir and emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only bictegravir and emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only efavirenz and emtricitabine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Product containing only emtricitabine (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only emtricitabine in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Bictegravir and emtricitabine and tenofovir only product in oral dose form Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Efavirenz and emtricitabine and tenofovir only product in oral dose form Has active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 10 mg/mL oral solution Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 10 mg/mL oral solution Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 1
Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Emtricitabine- and rilpivirine- and tenofovir-containing product in oral dose form Has active ingredient True Emtricitabine (substance) Inferred relationship Some 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Emtricitabine (substance) Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Emtricitabine (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start